Cite
HARVARD Citation
Salvi, F. et al. (2019). Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL). Leukemia & lymphoma. 60 (12), pp. 2890-2898. [Online].